{"id":"81f9fc65-d4dc-50e8-98f3-fc356024ff9a","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-food-is-required","predicate":"increases","statement":"When 1.5 gram doses were given to three volunteers, measurable plasma concentrations of 17 to 134 nanomoles per litre were found only if mebendazole was given together with a fatty meal, in a patient with cholestasis plasma concentrations were higher than in the three normal subjects, and in patients on long-term treatment the increase in plasma concentration after a 1 gram dose varied between 0 and 500 nanomoles per litre, so that monitoring plasma levels during long-term therapy appears advisable.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"e7a4bda9-a537-51e6-9370-8c742bf46e7e","mechanism_event_label":"Without fat in the meal the drug does not reach the blood at all, and between patients the levels vary from nothing to a great deal.","subject":{"id":"bbf29d55-a2b1-5d88-9b19-c96e62ce1771","slug":"fatty-meal","display_name":"A meal containing fat, taken with the dose","entity_type_key":"chemical_species"},"object":{"id":"42246bab-bc05-54aa-bed7-28c5ea57976c","slug":"plasma-concentration","display_name":"Plasma concentration of mebendazole","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"e7a4bda9-a537-51e6-9370-8c742bf46e7e","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-food-is-required-event","event_type":"observed_intervention","label":"Without fat in the meal the drug does not reach the blood at all, and between patients the levels vary from nothing to a great deal.","description":"When 1.5 gram doses were given to three volunteers, measurable plasma concentrations of 17 to 134 nanomoles per litre were found only if mebendazole was given together with a fatty meal, in a patient with cholestasis plasma concentrations were higher than in the three normal subjects, and in patients on long-term treatment the increase in plasma concentration after a 1 gram dose varied between 0 and 500 nanomoles per litre, so that monitoring plasma levels during long-term therapy appears advisable.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"c42f1791-ecdc-584a-b45d-99dc23ededff","slug":"oral-bioavailability","display_name":"Oral bioavailability","entity_type_key":"cellular_process"},"role":"affected_process","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"f8582a13-fc2e-5127-a61f-5b0594e54069","slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"},"role":"affected_drug","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"bbf29d55-a2b1-5d88-9b19-c96e62ce1771","slug":"fatty-meal","display_name":"A meal containing fat, taken with the dose","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"42246bab-bc05-54aa-bed7-28c5ea57976c","slug":"plasma-concentration","display_name":"Plasma concentration of mebendazole","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/mebendazole-research/7418715.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b3e200ec505a4a58edacfcf8a51f1073d528d8fc7718fd5cd10a6ca15cbded10\", \"start_char\": 0, \"end_char\": 812, \"text_sha256\": \"b3e200ec505a4a58edacfcf8a51f1073d528d8fc7718fd5cd10a6ca15cbded10\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Plasma concentrations in three volunteers given 1.5 gram doses and in patients on long-term treatment","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"1.5 gram oral doses given with and without a fatty meal","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Three volunteers. The finding that concentrations were measurable only with food is the substantive result; the cholestasis observation is a single patient.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.","comparator":null,"unit":null,"notes":"","entity":{"slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Without fat in the meal the drug does not reach the blood at all, and between patients the levels vary from nothing to a great deal.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[mbz-p7418715] Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results. (1980). https://pubmed.ncbi.nlm.nih.gov/7418715/ DOI: 10.1007/bf00558451","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Plasma","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"4ba6723a-901a-58eb-8d86-cbe29ab01f27","evidence_kind":"source_excerpt","locator":"Lines 420-431","start_line":420,"end_line":431,"excerpt":"### mbz-food-is-required\nWhen 1.5 gram doses were given to three volunteers, measurable plasma concentrations of 17 to 134 nanomoles per litre were found only if mebendazole was given together with a fatty meal, in a patient with cholestasis plasma concentrations were higher than in the three normal subjects, and in patients on long-term treatment the increase in plasma concentration after a 1 gram dose varied between 0 and 500 nanomoles per litre, so that monitoring plasma levels during long-term therapy appears advisable.\nCondition category: biomarker_context\nnutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.\nplain_language: Without fat in the meal the drug does not reach the blood at all, and between patients the levels vary from nothing to a great deal.\norganism: Human\ntissue_or_cell_type: Plasma\nexperimental_model: Plasma concentrations in three volunteers given 1.5 gram doses and in patients on long-term treatment\nlimitations: Three volunteers. The finding that concentrations were measurable only with food is the substantive result; the cholestasis observation is a single patient.\nexposure: 1.5 gram oral doses given with and without a fatty meal\nevidence_span: {\"source_cache\": \"artifacts/mebendazole-research/7418715.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b3e200ec505a4a58edacfcf8a51f1073d528d8fc7718fd5cd10a6ca15cbded10\", \"start_char\": 0, \"end_char\": 812, \"text_sha256\": \"b3e200ec505a4a58edacfcf8a51f1073d528d8fc7718fd5cd10a6ca15cbded10\"}\n[mbz-p7418715] Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results. (1980). https://pubmed.ncbi.nlm.nih.gov/7418715/ DOI: 10.1007/bf00558451","model_system":"Plasma concentrations in three volunteers given 1.5 gram doses and in patients on long-term treatment","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [mbz-p7418715] Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results. (1980). https://pubmed.ncbi.nlm.nih.gov/7418715/ DOI: 10.1007/bf00558451","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"06104773-03d0-5e5c-b9da-eb484e7be657","stable_key":"import-f2ec2007-88ff-5a96-a73b-8b5085e9cea9","title":"Mebendazole: the tubulin it binds, why that is selective, the crystal form that decides whether any of it works, and the off-target that became an oncology programme (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"58b652636677e5033fd1dd555744485fcef18f21a97dcf68723fe072b656f413","revision_id":"a2cd9c22-0549-52ca-a653-8a0c2362ec85","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}